Pharma's Almanac TV
PA TV
Follow the Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Current Issue
Archive
Reports
2021 Gene Therapy Report
2021 Biologics Report
2021 Sterile Drug Products Report
2021 API Market Report
2020 OSD Market Report
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
Clinical Trials
498 Articles Available
1
21
Can't find what you're looking for? Try our
advanced search
.
Cell and Gene Therapy Clinical Trials
Minimizing Patient Burden in Cell and Gene Therapy Trials
PAO-04-21-CL-03
Direct-to-Patient
Supporting Global Decentralized and Virtual Clinical Trials During Challenging Times and Beyond
PAO-03-21-CL-05
Oncology Clinical Trials
Accelerating Oncology Clinical Research Remotely
PAO-04-21-CL-02
Endpoints
NeuroRx Announces ZYESAMI™ Met the Primary Endpoint of Its Phase 2b/3 Clinical Trial and Also Demonstrated a Meaningful Benefit in Survival from Critical COVID-19
PR-M03-21-005
COVID-19 Impacts
Q: Putting aside COVID-19 vaccines and therapeutics, what do you think will be the most significant development in the industry in 2021?
PAO-03-21-NI-01
Clinical Trials
Modern Strategies for Dermatology Clinical Trials
PAP-Q4-20-CL-021
Mobile Research Nursing
Mobile Research Nursing: Evolving to Meet Pandemic Challenges
PAP-Q4-20-CL-013
Feature Story
Wearable Technology: Innovation, Adherence, and Clinical Outcomes
PAP-Q4-20-NI-002
Feature Story
Wearable Technology: Their Future in Clinical Trials and the Real World
PAP-Q4-20-NI-004
The Future of Healthcare
How Does SanaClis Envision the Future of the Pharma/Biopharma Industry?
PAP-Q4-20-RT2-014
The Future of Healthcare
How Does Yourway Envision the Future of the Pharma/Biopharma Industry?
PAP-Q4-20-RT2-016
The Future of Healthcare
How Does Globyz Biopharma Services Envision the Future of the Pharma/Biopharma Industry?
PAP-Q4-20-RT2-003
Decentralized Clinical Trials
Leveraging Digitally Reported Outcomes in Clinical Trials
PAO-11-20-CL-04
COVID-19 Vaccine
Russia's Sputnik V COVID-19 Vaccine Is 91% Effective
PR-M11-20-023
Clinical Trials
The Bristol Myers Squibb Foundation and National Medical Fellowships Launch $100 Million Program to Help Increase Diversity and Inclusion in Clinical Trials
PR-M11-20-015
COVID-19 Test
100% Remission Rate Reported in Third Dose Cohort of Actimab-A CLAG-M Phase 1 Combination Trial in Patients with Relapsed or Refractory AML
PR-M11-20-003
Phase III
Soligenix Announces Phase 3 FLASH Study Continues to Demonstrate Positive Benefits in Patients with Cutaneous T-Cell Lymphoma
PR-M10-20-14
Lilly Statement on the NIAID Decision to Pause Enrollment in ACTIV-3 Clinical Trial
PR-M10-20-09
COVID-19 Long-Acting AntiBody (LAAB) Combination AZD7442 Rapidly Advances into Phase III Clinical Trials
PR-M10-20-07
Decentralized Trials
Facilitating the Full Spectrum of Decentralized Trials
PAP-Q3-20-CL-009
Decentralized Trials
Protecting Clinical Research and Patients Through Decentralized Trial Strategies
PAP-Q3-20-CL-025
Feature Story
The COVID-19 Pandemic Magnifies Pharmaceutical Supply Chain Issues
PAP-Q3-20-NI-002
The Future of Healthcare
How Is Sanaclis Evolving its Business Model to Meet the Future of Healthcare?
PAP-Q3-20-RT2-010
The Future of Healthcare
How Is Globyz Evolving its Business Model to Meet the Future of Healthcare?
PAP-Q3-20-RT2-001
1
21
»
